Glutathione powder for reconstitution for IV/IM injection
Certifications
Glutathione powder for reconstitution for IV/IM injection
Description
Glutathione 600 mg Powder Vial (TAD) is a sterile pharmaceutical-grade vial containing lyophilised reduced glutathione (GSH) for reconstitution and subsequent intravenous or intramuscular injection under medical supervision. Glutathione is a naturally occurring antioxidant that helps neutralise reactive oxygen species, supports cellular detoxification and protects tissues from oxidative damage. The injectable form ensures rapid systemic delivery and high bioavailability, used in clinical settings to manage oxidative stress, support detoxification, and in some contexts for antioxidant therapy. This product is supplied as a powder vial only and requires reconstitution with sterile water for injection by a qualified healthcare professional before administration.
Bnefits
Provides a high-dose systemic antioxidant source to help protect cells and tissues from oxidative stress.
Supports endogenous detoxification pathways, particularly in conditions associated with oxidative damage or toxin exposure.
Rapid bioavailability upon reconstitution and injection, delivering glutathione directly into the bloodstream.
Potential supportive therapy in oxidative stress–related conditions, liver support, and recovery from inflammation or cellular damage.
When prescribed and administered by a qualified clinician, allows precise dosing and monitoring under medical supervision.
Indications
Intravenous or intramuscular supplementation of glutathione when endogenous antioxidant levels are deficient or oxidative stress is elevated (as determined by a qualified clinician).
Adjunctive therapy in conditions linked to oxidative stress, toxin exposure, or hepatic detoxification support, as assessed by treating physician.
Use as part of antioxidant therapy regimens under medical supervision; not intended for cosmetic or aesthetic use unless specifically prescribed by a qualified medical professional.
Reduced glutathione (lyophilised powder), nominal dose 600 mg per vial.
Sterile excipients required for lyophilisation (e.g. stabilisers, buffer agents) as per manufacturer specification (exact composition not publicly disclosed).
Formulation
Lyophilised (freeze-dried) powder vial containing 600 mg glutathione for reconstitution.
Intended for reconstitution with sterile water for injection (not included) in a controlled clinical setting.
Sterile, single-dose vial; once reconstituted, the solution must be used immediately or as per clinical protocol.
Packaging
Single glass vial containing 600 mg glutathione powder (lyophilised).
Sterile packaging designed for pharmaceutical distribution; outer box bears batch number, expiry date and handling instructions.
No diluent included — water for injection must be supplied separately by the administering clinician.
Usage
For use only under medical supervision by qualified healthcare professionals.
Reconstitute the vial using sterile water for injection, following aseptic technique and standard reconstitution procedures.
After reconstitution, inspect the solution for particulate matter or discoloration; do not use if not clear or if contamination is suspected.
Administer via intravenous or intramuscular injection as per the prescribing clinician’s protocol at an appropriate dose schedule.
Discard any unused portion of the reconstituted solution according to local regulations; do not store for later use unless specified in product documentation.
Ensure patient monitoring for any adverse reactions during and after administration according to clinical guidelines.
Contraindications
Hypersensitivity or allergy to glutathione or any of the excipients used in the vial.
Severe renal or hepatic impairment, unless assessed and approved by a qualified clinician.
Not to be used if the vial or packaging is damaged, or if sterility is compromised.
Not intended for use as a cosmetic skin-lightening agent; such off-label use carries risk and should not be undertaken without medical supervision.
Adverse Effects
Possible injection-site reactions (pain, redness, swelling) when administered intramuscularly.
Rare systemic effects such as allergic reaction (rash, urticaria), gastrointestinal upset, or hypotension depending on dose and patient sensitivity.
Risk of contamination or infection if aseptic reconstitution and injection technique are not strictly followed.
Potential for oxidative imbalance if misused (although glutathione is generally well tolerated when used correctly).
Storage Conditions
Store the powder vial in a cool, dry place, protected from light and moisture, at the temperature specified by the manufacturer (commonly 2–25 °C).
Keep the vial in its original sealed packaging until reconstitution.
Do not freeze. Protect from extreme heat, humidity and direct sunlight.
Use immediately after reconstitution; do not store reconstituted solution unless compliant with clinical and pharmacopeial standards.
Keep out of reach of unauthorized persons and children.
Duration
Determined by the prescribing clinician \u2014 may involve single or multiple injection sessions depending on clinical indication and patient response.
Onset
Rapid onset of systemic antioxidant effect following reconstitution and intravenous or intramuscular administration; clinical effects depend on underlying condition treated and may require repeated dosing.
